Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4


Journal

Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 29 10 2024
Statut: ppublish

Résumé

HIV-1 transmission precipitates a stringent genetic bottleneck, with 75% of new infections initiated by a single genetic variant. Where multiple variants initiate infection, recipient set point viral load (SpVL) and the rate of CD4

Identifiants

pubmed: 39471873
doi: 10.1098/rsif.2024.0255
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20240255

Subventions

Organisme : European Research Council
Pays : International
Organisme : Medical Research Council
Pays : United Kingdom

Auteurs

James Baxter (J)

Usher Institute, Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK.

Ch Julián Villabona-Arenas (CJ)

Faculty of Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Robin N Thompson (RN)

Mathematical Institute, University of Oxford, Oxford OX2 6GG, UK.

Stéphane Hué (S)

Faculty of Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Roland R Regoes (RR)

Department of Environmental Systems Science, Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.

Roger D Kouyos (RD)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Huldrych F Günthard (HF)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Jan Albert (J)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.

Andrew Leigh Brown (A)

Institute of Evolutionary Ecology, The University of Edinburgh, Edinburgh, UK.

Katherine E Atkins (KE)

Usher Institute, Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK.
Faculty of Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH